Page 5,684«..1020..5,6835,6845,6855,686..5,6905,700..»

EmberClear Completes Technical Feasibility Study for a Natural Gas to Liquids Project in Natchez, MS

Posted: Published on February 20th, 2013

CALGARY , Feb. 19, 2013 /CNW/ - EmberClear Corp. (EMB.V) ("EmberClear" or the "Company") is pleased to announce its subsidiary, EmberClear GTL MS Inc. ("EmberClear GTL"), has completed the technical feasibility study for a natural gas to liquids project (the "Project") in Natchez, Mississippi. It is anticipated that if the Project proceeds it will be capable of producing 4,000 tons of methanol per day or 14,000 barrels of gasoline per day. Abundant natural gas supplies in North America can produce high value transportation fuels using proven technologies. This Project's proximity to competitively priced sources of natural gas and the Gulf Coast petrochemical complex creates the potential for attractive pricing, efficient access to markets and multiple modes of transportation. "It is our intent to take advantage of the recently available long-term natural gas contracts and address the desire for more domestic energy. The USA may continue to import oil for decades but facilities like ours could potentially reduce such imports while providing lower cost energy," stated Nick Cohen , Chief Operating Officer. EmberClear has access to an 800-acre site along the Mississippi River. "This site is served by American Midstream's Midla pipeline system that intersects three interstate gas pipelines providing us … Continue reading →

Posted in MS Treatment | Comments Off on EmberClear Completes Technical Feasibility Study for a Natural Gas to Liquids Project in Natchez, MS

Edison Pharmaceuticals & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C …

Posted: Published on February 20th, 2013

MOUNTAIN VIEW, Calif., Feb. 19, 2013 /PRNewswire/ --Edison Pharmaceuticals today announced the initiation of a phase 2 clinical trial entitled, "Double-Blind, Placebo-Controlled Clinical Trial of EPI-743 in Patients with Cobalamin C Defect." The trial is a placebo-controlled study lasting 12 months, preceded by a six-month run-in phase for all patients to establish a defined clinical and metabolic baseline. The primary endpoint is improvement in visual function with secondary outcome measurements assessing neurologic and neuromuscular function, glutathione biomarkers, quality of life, as well as safety parameters. More information on study specifics is available at http://www.ClinicalTrials.gov. The rationale underlying this investigation is centered on understanding whether EPI-743 a therapeutic targeting primary defects in electron transport might hold therapeutic benefit in disorders of intermediary metabolism that also result in redox disturbances. "Cobalamin C deficiency represents an inherited disorder that induces perturbations in the metabolism of glutathione. Given the central role of glutathione in cellular redox balance and antioxidant defense systems, we are eager to explore whether a therapeutic that increases glutathione such as EPI-743 will provide clinical benefit," statedProfessor Carlo Dionisi-Vici, Division of Metabolism, Bambino Gesu Children's Hospital the trial's principal investigator. Cobalamin C Deficiency Syndrome Cobalamin C (Cbl-C) defect belongs to the … Continue reading →

Comments Off on Edison Pharmaceuticals & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C …

Natural Hormone Replacement Therapy doctors DENNIS MA 02638 Hormone treatment – Video

Posted: Published on February 20th, 2013

Natural Hormone Replacement Therapy doctors DENNIS MA 02638 Hormone treatment Natural hormone replacement clinics DENNIS MA 02638 Doctors who treat hormone imbalances naturally. HRT Therapy DENNIS MA. HRT Doctors in DENNIS. Hormone Therapy clinics DENNIS MA 02638. For a FREE CONSULTATION, call 1-800-617-3610, or go to http://www.capecodpainrelief.com By: CapeCodPM … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Natural Hormone Replacement Therapy doctors DENNIS MA 02638 Hormone treatment – Video

9 Investigates: Medical Center that offered hormone replacement

Posted: Published on February 20th, 2013

CHARLOTTE, N.C. A former Charlotte doctor's office offered to boost your energy and make you feel younger, but Channel 9 uncovered that patients may not know the hormone treatment therapy they received could cause health problems. Eyewitness News found out how North Carolina's medical board took action. Charlotte residents may be familiar with HRC Medical Center that offered hormone replacement treatment last fall. When Eyewitness News found a North Carolina Medical Board order from October requiring that HRC's Medical Director Dr. John Murphy Jr. disassociate himself from the practice, Eyewitness News starting digging further at the State Medical Board office in Raleigh. Board attorney Marcus Jimison said HRC doctors prescribed patients hormone therapy even though their levels were normal. "They are paying for this and it is not cheap. Yet they are not being told there are serious health consequences," said Jimison. He said those possible side effects can include cancer, heart disease and blood clots, plus other issues when hormone levels are too high. Jimison said some HRC patients experienced those exact problems. "Then when they started developing female characteristics, HRC would prescribe Famara, a cancer drug, used off label to counteract these side effects," he said. Read more: … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on 9 Investigates: Medical Center that offered hormone replacement

Summit4StemCell Research – Video

Posted: Published on February 20th, 2013

Summit4StemCell Research Sherrie Gould, NP, describes the non-embryonic stem cell research underway at the Scripps Research Institute. By: Jeff Seckendorf … Continue reading →

Posted in Stem Cell Research | Comments Off on Summit4StemCell Research – Video

Westminster Faith Debate: Stem cell research, abortion and the ‘soul of the embryo’? – Video

Posted: Published on February 20th, 2013

Westminster Faith Debate: Stem cell research, abortion and the'soul of the embryo'? A significant number of people believe that human life begins at conception, but this does not necessarily mean they are opposed to abortion. The first debate in the 2013 series was chaired by Prof Linda Woodhead with a panel including Prof John Harris, Revd Dr Gerard Hughes, Dr David Albert Jones and Dr Abdul Majid Katme. Listen to podcasts of the presentations, responses and discussion from this first debate and view texts of the academic presentations here: http://www.religionandsociety.org.uk By: lancasteruniversity … Continue reading →

Posted in Stem Cell Research | Comments Off on Westminster Faith Debate: Stem cell research, abortion and the ‘soul of the embryo’? – Video

Faith Debate Highlights: Stem cell research, abortion and the ‘soul of the embryo’? – Video

Posted: Published on February 20th, 2013

Faith Debate Highlights: Stem cell research, abortion and the'soul of the embryo'? Highlights from the first 2013 Westminster Faith Debate: Stem cell research, abortion and the'soul of the embryo'? http://www.religionandsociety.org.uk By: lancasteruniversity … Continue reading →

Posted in Stem Cell Research | Comments Off on Faith Debate Highlights: Stem cell research, abortion and the ‘soul of the embryo’? – Video

Regenerative medicine and Stem cells Partnering Terms and Agreements

Posted: Published on February 20th, 2013

NEW YORK, Feb. 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Regenerative medicine and Stem cells Partnering Terms and Agreements http://www.reportlinker.com/p01098514/Regenerative-medicine-and-Stem-cells-Partnering-Terms-and-Agreements.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy The Regenerative Medicine and Stem Cells Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the Regenerative medicine and Stem cells partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors regenerative medicine and stem cells technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest regenerative medicine and stem cells agreements including cell therapy agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process … Continue reading →

Posted in Stem Cell Research | Comments Off on Regenerative medicine and Stem cells Partnering Terms and Agreements

Stem Cell Therapeutics Announces Proposed Offering of Units

Posted: Published on February 20th, 2013

TORONTO, ONTARIO--(Marketwire - Feb. 19, 2013) - NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) a life sciences company developing stem cell-related technologies, today announced that it is initiating a marketed offering of units, each unit will be comprised of a common share and common share purchase warrants in a proportion to be determined. The offering is to be effected in each of the Canadian provinces of British Columbia, Alberta, Manitoba, Ontario and Nova Scotia by way of a prospectus supplement to SCT's base shelf prospectus of March 1, 2011. The number of units to be distributed, the price of each unit and the exercise price of each whole common share purchase warrant will be determined in context of the market with final terms to be determined at the time of pricing. Euro Pacific Canada Inc.is acting as theagent for the offering. The purpose of the offering is to provide the resources necessary to conclude the merger of Trillium Therapeutics Inc. into SCT announced February 4th, 2013 and to permit the exercise of the option by SCT to acquire the license to the Tigecycline Intellectual Property from … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Therapeutics Announces Proposed Offering of Units

Bina launches package of hardware + software + apps to use big data to cure cancer

Posted: Published on February 20th, 2013

Dr.Narges Bani Asadi says cancer is a genetic disease, and she is using technology to fight it. Asadi is the founder and CEO ofBina, a healthcare startup working to make personalized medicine a reality. Bina applies big data analytics to genomics, making it possible to sequence the human genome in a matter of hours rather than days or weeks. Today, Bina launched its commercial product. The platform provides physicians, clinicians, and researchers with a detailed picture of a patients health.From there, they can make data-driven diagnoses and prescribe individualized courses of treatment. Medicine today is very experimental, said founder and CEO Narges Bani Asadi in an interview with VentureBeat. Before, there was a bottle neck to crunch the massive amount of genomic data. At Bina, we have created the fastest, most highly accurate, cost-efficient processing solution available in the market today. The next step is to incorporate this genomic data into medical use. Data-driven, information-based medicined is much more targeted. Personalizing therapies for different diseases means a longer and healthier quality of life for all humans. There are thousands of genetic disorders. In 2013, over 580,000 Americans are expected to die of cancer. One in twenty babies born in the … Continue reading →

Comments Off on Bina launches package of hardware + software + apps to use big data to cure cancer

Page 5,684«..1020..5,6835,6845,6855,686..5,6905,700..»